Sellbyville, DE -- (SBWIRE) -- 04/30/2019 -- The HLA Typing for Transplant Market is set to exceed USD 0.8 billion by 2025; according to a new research study published by Global Market Insights, Inc. HLA typing for transplant market will witness lucrative growth over the forecast timeframe. Growing demand for solid organ transplants will drive HLA typing for transplant industry growth over the forecast years. These lifesaving transplants are indispensable for treating patients suffering from heart, liver, lung, kidney disorders as they help to increase patient survival.

Growing geriatric population will further augment industry expansion as individuals from this stratum are frequently referred for organ transplant procedures due to age or chronic ailment related organ failure. Furthermore, an increasing number of older adults are becoming organ donors. Technological advancements, particularly in molecular assays will further propel growth in HLA Typing for Transplant Market. For instance, in February 2017, Immucor launched its MIA FORA NGS FLEX HLA typing assay which provides a comprehensive coverage of up to 11 genes.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1653

Molecular assays business segment will grow at a robust rate during the forecast years owing to increasing use of sequence based methods such as sanger sequencing and next generation sequencing for typing procedures. Reagents and consumables industry segment held significant industry share in 2018 and is poised to grow at a rapid pace during the forecast timeframe as they are required in large quantities for HLA typing.

Application of HLA typing in research is slated to increase at a lucrative pace owing to the spur in research and development activities being carried out to develop methods which are more advanced and accurate as compared to existing ones. Hospital end user segment will grow at a rapid pace owing to the increasing number of organ transplant procedures being performed in these settings. Growing number of hospitals in several countries because of the healthcare infrastructure expansion plans will further augment segment growth.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
- CareDx, Inc.
- Bio-Rad Laboratories
- Bio Reference Laboratories Inc
- GenDx
- Pacific Biosciences Inc.
- Immucor
- QIAGEN
- inno-train Diagnostik
- Luminex Corporation
- Omixon
- Kalila Medical (Abbott Laboratories)

HLA typing is essentially the study of genes which are present in the genome sequence of humans and is considered of immense significance for research in drug hypersensitivity research, tissue transplantation matching, and autoimmune disease research. These genes are deemed as highly polymorphic and consist a large number of alleles which are helpful in finding foreign antigens. As a result of this complexity, analyzing these genes with other sequencing technologies has become both challenging and highly expensive for the leading players of HLA typing for transplant industry. However, considering the advantages of leukocyte antigen typing in transplants, a number of diagnostics centers, research institutions, and private players have been employing this technology on a wider scale, consequentially providing favorable impetus to the worldwide HLA typing for transplant market.

Meanwhile, it has been observed that in order to boost the revenue growth of the overall HLA typing for transplant market, renowned participants of this business space have been consistently making efforts to enhance and refine the existing technology and the prevailing standard practices. Consequentially, a host of HLA-based typing services providing firms are increasingly adopting advanced software-reliant technologies to ensure extensive commercialization of diagnostic procedures for organ transplantation. Regarded as the global leader and one of the pioneers in providing high-resolution HLA sequence-based typing services, HistoGenetics for instance has recently declared that the firm has seized a multi-year deal to perform HLA typing by utilizing PacBio® sequencing that would drive demand for several thousand samples each week over the forthcoming years.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1653

Prominent industry players in HLA Typing for Transplant Market are include CareDx, Pacific Biosciences of California, Illumina, Thermo Fischer Scientific, GenDx and Immucor. The industry players employ various strategies such as distributor agreements, product portfolio expansion, acquisitions, collaborations and partnerships for increasing their industry shareholding. For instance, in July 2017, Thermo Fischer Scientific acquired Linkage Biosciences. Linkage Biosciences is now a part of Thermo Fischer's transplant diagnostics business along with One Lambda. The acquisition has broadened the company's product portfolio in turn strengthening its presence in the HLA typing for transplant industry.

Chapter 1 Methodology

1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary

Chapter 2 Executive Summary

2.1 HLA typing for transplant industry 3600 synopsis, 2014 – 2025
2.1.1 Business trends
2.1.2 Technology trends
2.1.3 Product and services trends
2.1.4 Application trends
2.1.5 End-use trends
2.1.6 Regional trends

Browse Full Report@ https://www.gminsights.com/industry-analysis/hla-typing-for-transplant-market

Chapter 3 HLA Typing for Transplant Industry Insights

3.1 Industry segmentation
3.2 Industry landscape, 2014- 2025
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing number of solid organ transplants
3.3.1.2 Technological advancements
3.3.1.3 Increasing geriatric population
3.3.2 Industry pitfalls and challenges
3.3.2.1 Significant gap between number of organs donated and organs required
3.3.2.2 High costs of molecular tests

Data Tables

TABLE 1. HLA typing for transplant industry 3600 synopsis, 2014 – 2025
TABLE 2. Global HLA typing for transplant market, 2014-2025 (USD Million)
TABLE 3. Global HLA typing for transplant market, by technology, 2014-2025 (USD Million)
TABLE 4. Global HLA typing for transplant market, by product and services, 2014-2025 (USD Million)
TABLE 5. Global HLA typing for transplant market, by application, 2014-2025 (USD Million)
TABLE 6. Global HLA typing for transplant market, by end-use, 2014-2025 (USD Million)
TABLE 7. Global HLA typing for transplant market, by region, 2014-2025 (USD Million)
TABLE 8. Non-Molecular assays market, by region, 2014 – 2025 (USD Million)
TABLE 9. Serological assays market, by region, 2014 – 2025 (USD Million)
TABLE 10. Mixed lymphocyte culture assay market, by region, 2014 – 2025 (USD Million)